A spherical lesion with decreased volume and low blood flow.

<p>Three months after treatment the spherical lesion's volume decreased significantly, and there is no reinforcement of blood flow at the lesion with strengthening in tissues surrounding the lesion.</p

Forest plot of human papillomavirus 16 prevalence in oral squamous cell carcinoma and control samples.

<p>OSCC: oral squamous cell carcinoma.</p

Funnel plot of the included studies of oral squamous cell carcinoma risk in HPV16 infection.

<p>Funnel plot of the included studies of oral squamous cell carcinoma risk in HPV16 infection.</p

A spherical lesion with significantly decreased volume and no blood flow.

<p>Six months after treatment there is a significant decrease in the volume of the spherical lesion, with no reinforcement of its blood flow. There is no evident increase in blood flow of tissues surrounding the lesion.</p

Characteristics of studies investigating human papillomavirus (HPV) 16 infection in oral squamous cell carcinoma (OSCC) and control samples.

<p>Pos: Positive; Neg: Negative.</p

Liver function and AFP values of 25 patients with malignant liver tumors before and after treatment with Radiofrequency Ablation combined with Low-Frequency Ultrasound Radiation with Microbubbles.

<p>Note:</p>a<p>compared to pre-treatment, <i>P</i><0.05;</p>b<p>compared to pre-treatment, <i>P</i>>0.05.</p

Forest plot of human papillomavirus prevalence in oral squamous cell carcinoma and control samples.

<p>OSCC: oral squamous cell carcinoma.</p

A spherical lesion with enhanced blood flow.

<p>Before treatment, a spherical lesion and enhanced blood flow is shown by contrast ultrasound.</p

Funnel plot of the included studies of oral squamous cell carcinoma risk in HPV infection.

<p>Funnel plot of the included studies of oral squamous cell carcinoma risk in HPV infection.</p

OTUD5 deubiquitininates p53.

<p>(A) In vitro translated p53 was pre-incubated for 90 min with a bacterially expressed MDM2 and subsequently immunoprecipitated with an anti-p53 antibody. Immunoprecipitated p53 was then incubated with in vitro translated OTUD5, followed by western blotting with anti-UB to detect the ubiquitination of p53 and blotted with anti-p53, anti-OTUD5 and anti-MDM2 as loading control. (B) OTUD5 does not affect the auto-ubiquitination of MDM2 in vitro. Immobilized GST–Mdm2 protein was incubated with His-OTUD5, E1, E2 and Ub as indicated. (C,D) The H1299 cells were transfected with the indicated combinations of expression vectors. Cells, 24 h after transfection, were treated with MG132 (5 μM) for 3 h and then lysed. Cell lysates were immunoprecipitated with anti-HA antibody (against HA-p53) and immunoblotted with anti-Myc antibody (against Myc-ubiquitin).</p